Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events. - Wikidata - awgldk - TriplyDB

Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events.

Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events.

http://www.wikidata.org/entity/Q37188800

about

Cardiovascular magnetic resonance in systemic hypertension Review of journal of cardiovascular magnetic resonance 2010.Review of Journal of Cardiovascular Magnetic Resonance 2009 Cardiovascular magnetic resonance in carotid atherosclerotic disease.Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography Variations in atherosclerosis and remodeling patterns in aorta and carotids.Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.Regular cocaine use is associated with increased systolic blood pressure, aortic stiffness and left ventricular mass in young otherwise healthy individuals Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study Multimodal cardiovascular magnetic resonance quantifies regional variation in vascular structure and function in patients with coronary artery disease: relationships with coronary disease severity.Reference Values for Cardiac and Aortic Magnetic Resonance Imaging in Healthy, Young Caucasian Adults.Carotid artery disease and stroke: assessing risk with vessel wall MRI.Effect of Angiotensin II Type I Receptor Blockade with Valsartan on Carotid Artery Atherosclerosis: A Double Blind Randomized Clinical Trial Comparing Valsartan and Placebo (EFFERVESCENT)Relationship between particulate matter exposure and atherogenic profile in "Ground Zero" workers as shown by dynamic contrast enhanced MR imaging.The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis.The future of imaging in cardiovascular disease intervention trials: 2017 and beyond.Atherosclerosis imaging using 3D black blood TSE SPACE vs 2D TSE.Evaluation of Fibrous Cap Rupture of Atherosclerotic Carotid Plaque with Thin-Slice Source Images of Time-of-Flight MR Angiography.MRI-based determination of reference values of thoracic aortic wall thickness in a general population.Atherosclerotic plaque burden of middle cerebral artery and extracranial carotid artery characterized by MRI in patients with acute ischemic stroke in China: association and clinical relevance.Sex, body mass index, and blood pressure are related to aortic characteristics in healthy, young adults using magnetic resonance vessel wall imaging: the AMBITYON study.Carotid versus coronary atherosclerosis burdens in acute compared with chronic symptomatic coronary artery disease.

P2860

Q30466693-C5C02306-786B-48AA-81D7-C8E23281D933 Q30474025-B982244C-B4BD-45C1-A38A-6103C582F110 Q30484444-B2787173-A83B-42EB-B5F7-D195861CCFD0 Q33592226-E0B31C12-512B-4430-9ED9-B7DFA5F10450 Q33719962-EA595C7A-2A9C-4ACC-9F38-45B061DF9DC3 Q33763488-99645620-18B9-4FE8-90EC-4F7B1B7435A4 Q33956714-89174E63-8334-41DD-9B9B-9F930994E51E Q34120778-2EB3EA88-3E45-4227-B5FF-5DA87412CF7F Q35143616-402E2FEF-1393-4450-90F5-C0E756C33039 Q35580970-21CC5727-9195-4FB8-9AC7-3D84EA10DC7E Q35666715-BF8E174E-A9F5-48ED-A992-CFE75DDA05B6 Q36161513-7B771618-62CB-4315-AF6C-67DA7FFDA90E Q36417897-54358D6B-1452-4FEF-993C-1D6A6D9BEA5F Q36708368-DB7B347D-9A2D-4133-B66C-836E113FD85F Q36824109-74856A51-3E7B-4A35-9EFF-DF9D970A6361 Q37296851-325861FF-6915-445B-9037-6E727F9BDBF9 Q38800754-E126929E-7146-4884-9C45-F2D99F5DE91B Q40028808-B7F02AB7-D764-4676-9267-EA5A52B54A4B Q41321282-69AA7FC9-9DE7-400B-A179-4B10715F6495 Q43514957-7CB2F921-092F-453B-9924-F8E9E4652A4B Q48333296-B78E422C-D7F3-488C-A900-B2462531A6C7 Q50300142-7D4C5426-85D9-4BD1-A690-8AA283243EB5 Q53285289-644291D6-C03E-4131-8843-F05D8E577181

P2860

Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events.

http://www.wikidata.org/entity/Q37188800

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cardiovascular magnetic resona ...... adverse cardiovascular events.

@en

Cardiovascular magnetic resona ...... adverse cardiovascular events.

@nl

type

label

Cardiovascular magnetic resona ...... adverse cardiovascular events.

@en

Cardiovascular magnetic resona ...... adverse cardiovascular events.

@nl

prefLabel

Cardiovascular magnetic resona ...... adverse cardiovascular events.

@en

Cardiovascular magnetic resona ...... adverse cardiovascular events.

@nl

P1433

Q37188800-08877A37-8CEB-4E46-B586-7A3D1F6AAFDC

P1476

Q37188800-2881B419-8CCE-4BBE-9B55-254F0DEEBD6F

P2093

Q37188800-490BE09B-72E5-445B-9CE2-0016CB90F416

Q37188800-54DA8D3C-C69C-4F54-A7A0-E445F4B7C201

Q37188800-61020A6F-0A3E-4219-A759-37BB3958E584

Q37188800-6831D855-F599-4504-9A6B-1E44B87ACBCC

Q37188800-6C99E9BB-8F4D-4784-97CE-858C6DE81E6D

Q37188800-89873E31-1996-4776-8FB7-7F965D0B30DE

Q37188800-8B05D598-454A-4DCD-B809-B2578692EB5B

Q37188800-99271667-7E67-4193-ABC7-060E5D514702

Q37188800-99D7CD67-5B4F-4FD1-A22D-83144C09CC65

Q37188800-9BFCEC25-84F2-4540-A5A6-1AD648B150AA

P2860

Q37188800-0243BB8C-79ED-4E08-A6D9-423816926CE9

Q37188800-0C43E05F-C441-44A1-A0DA-1674C753A85B

Q37188800-155BD384-58CE-4233-B53C-6D1FC3DA0487

Q37188800-1CA438A0-B799-4D8C-9F36-D1786D857A02

Q37188800-2750E4A5-6A10-4350-BAB3-1DEE18DA0DEC

Q37188800-2D77519F-A289-4429-970E-CFD14F92CC2C

Q37188800-2F7E76C7-428C-405B-9491-5F07F1CA21F8

Q37188800-33F8023D-D734-42C9-9FB9-DA181A79D347

Q37188800-3D5B01E0-638B-4E96-9EAA-0C25C7277F96

Q37188800-3F98EBC0-3B21-4D63-BD49-49253D61E242

P2888

Q37188800-4EA4414B-89B3-4712-94CB-0D5F4D88B1C4

P304

Q37188800-E43D5999-46F1-4EE3-B2BA-BF630E850B8A

P31

Q37188800-31ED4752-BC7F-4C0D-BE14-0D6472BBE100

P356

Q37188800-48AF2915-B4E9-414D-9634-389DD9E4D301

P478

Q37188800-746F3309-6B3D-4395-9F11-1FF7DA69B005

P50

Q37188800-AC8F0DBF-0E41-47E5-BC33-A46A577755D9

Q37188800-B9479977-2239-41CC-BCC3-DAFFB67F2448

Q37188800-D88C3CDF-60F7-4607-9A5C-A3DA55048A5D

P577

Q37188800-F2D25A9A-4F8C-4E6B-9B4B-055450A5923D

P6179

Q37188800-BEB4CDCC-4A8B-4164-BD4C-2DFF7EC05A72

P698

Q37188800-FB64B8BA-4E55-4D9C-A2D3-23200DCC1C37

P921

Q37188800-3C1E785A-E7BB-4FD9-834C-5D3CDE66AB8D

Q37188800-B9A59D9E-628E-4BBC-A3E7-BF7F970ACBDF

P932

Q37188800-30A446BC-E8EF-4004-873F-96B208D4AA50

P356

1532-429X-11-10

P1433

Journal of Cardiovascular Magnetic Resonance

P1476

Cardiovascular magnetic resona ...... adverse cardiovascular events

@en

P2093

Hamza El Aidi

http://www.w3.org/2001/XMLSchema#string

Hiroaki Taniguchi

http://www.w3.org/2001/XMLSchema#string

Johan H C Reiber

http://www.w3.org/2001/XMLSchema#string

John E Postley

http://www.w3.org/2001/XMLSchema#string

Karen B Weinshelbaum

http://www.w3.org/2001/XMLSchema#string

Mark Woodward

http://www.w3.org/2001/XMLSchema#string

Michael Farkouh

http://www.w3.org/2001/XMLSchema#string

Paul Muntner

http://www.w3.org/2001/XMLSchema#string

Sameer Bansilal

http://www.w3.org/2001/XMLSchema#string

Samuel S Gidding

http://www.w3.org/2001/XMLSchema#string

P2860

Simvastatin with or without ezetimibe in familial hypercholesterolemia

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Prevention of ischemic stroke: overview of traditional risk factors.

Quantification in cardiac MRI.

Compensatory enlargement of human atherosclerotic coronary arteries.

Noninvasive surrogate markers of atherosclerosis.

Atherosclerotic plaque formation and risk factors.

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta.

P2888

1532-429x-11-10

P304

10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1532-429X-11-10

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Rob J van der Geest

Valentín Fuster Carulla

P577

2009-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1050151778

http://www.w3.org/2001/XMLSchema#string

P698

19393089

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

atherosclerosis

P932

2680849

http://www.w3.org/2001/XMLSchema#string